| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |